Literature DB >> 6726982

Hürthle cell tumors of the thyroid gland. A clinicopathologic review and long-term follow-up.

R H Caplan, R M Abellera, W A Kisken.   

Abstract

We reviewed the pathology and clinical follow-up of 26 patients with H urthle cell adenomas and three patients harboring H urthle cell carcinomas, who were treated at our medical center from 1950 to 1979. Although benign lesions could not be distinguished from malignant tumors by cytologic features alone, other pathologic features allowed differentiation. A total thyroidectomy was performed in only one patient; the remaining patients were treated by less extensive operations. None of the patients with benign adenomas, including those with tumors greater than 2 cm in diameter, experienced recurrent or metastatic disease. The period of observation varied from two to 22 years (mean, 8.5 +/- 7.7 years). We conclude that lobectomy is a satisfactory operation for removal of benign H urthle cell tumors, and reserve total or near-total thyroidectomy for cases displaying pathologic evidence of malignancy.

Entities:  

Mesh:

Year:  1984        PMID: 6726982

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  Benign Hürthle cell tumors of the thyroid: a diagnosis to be trusted?

Authors:  C S Grant; D Barr; J R Goellner; I D Hay
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.

Authors:  J J Ryan; I D Hay; C S Grant; L M Rainwater; G M Farrow; J R Goellner
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Surgical treatment of Hurthle cell tumors of the thyroid.

Authors:  Tzu-Chieh Chao; Jen-Der Lin; Miin-Fu Chen
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

4.  Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment.

Authors:  Adolfo Pisanu; Luigi Sias; Alessandro Uccheddu
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

5.  Hürthle cell carcinoma in an autonomous thyroid nodule in an adolescent.

Authors:  A R Siddiqui; S Karanauskas
Journal:  Pediatr Radiol       Date:  1995

6.  Proliferative cell nuclear antigen expression in follicular tumours of the thyroid with special reference to oxyphilic cell lesions.

Authors:  H Tateyama; Y P Yang; T Eimoto; T Tada; H Inagaki; T Nakamura; H Iwase; S Kobayashi
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes.

Authors:  Adolfo Pisanu; Barbara Di Chiara; Isabella Reccia; Alessandro Uccheddu
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

8.  Cell Cycle Regulatory Proteins p27(kip), Cyclins Dl and E and Proliferative Activity in Oncocytic (Hurthle Cell) Lesions of the Thyroid.

Authors:  Lincoln J. Maynes; Michael J. Hutzler; Nilima A. Patwardhan; Songtao Wang; Ashraf Khan
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.